HRT Financial’s OptiNose OPTN Stock Holding History

HRT Financial’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,357	Closed	-$43K	–	3009
2024 Q3	$43K	Sell	4,357 -253	-5%	-$3.69K	﹤0.01%	2124
2024 Q2	$71K	Buy	+4,610	New	+$77.2K	﹤0.01%	1799
2023 Q2	–	Sell	-7,832	Closed	-$226K	–	3030
2023 Q1	$226K	Buy	+7,832	New	+$209K	﹤0.01%	1873
2021 Q4	–	Sell	-5,198	Closed	-$233K	–	3828
2021 Q3	$233K	Sell	5,198 -1,272	-20%	-$53.4K	﹤0.01%	2579
2021 Q2	$301K	Buy	+6,470	New	+$330K	﹤0.01%	2135

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

HRT Financial's OPTN Position: Q4 2024 in Review

HRT Financial sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 4,357 shares — an estimated $43K sold.

HRT Financial first reported a position in OPTN in Q2 2021 and held it in 5 quarters. The position peaked at $301K in Q2 2021. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

HRT Financial reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
HRT Financial sold 4,357 OptiNose shares in Q4 2024, an estimated $43K.
HRT Financial first reported a position in OptiNose in Q2 2021 and held it in 5 quarters.
HRT Financial's OptiNose position peaked at $301K in Q2 2021.
40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.